Wheeler Bio
Oklahoma City, OK
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: Wheeler Bio
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Oklahoma City, OK
- Modalities
- Monoclonal Antibody, Bispecific Antibody, Fc-Fusion Protein, Recombinant Protein
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Wheeler Bio
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Bispecific Antibody, Fc-Fusion Protein, Recombinant Protein
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (4 modalities)
Recent News 9 articles
Wheeler Bio Announces Strategic Partnership with Mitsubishi Corporation to Accelerate Asia-Pacific Business Development - PR Newswire
Wheeler Bio Partners with Mitsubishi to Expand Asia Pacific Business Development - Contract Pharma
Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing - Morningstar
Wheeler Bio Announces Oversubscribed $35M Series, Plans for Expansion and Continued Growth - Business Wire
Alloy and Wheeler Bio Form Nonexclusive Preferred Service Offering - Genetic Engineering and Biotechnology News
CDMO scale up: Resilience, Wheeler, SHL strengthen US ops - BioProcess International
Wheeler Bio Appoints Jay Benson as Chief Operating Officer - BioSpace
From Global Pharma to Maryland’s Next-Gen CDMO: Yuk Chun Chiu’s Vision for Xcellon Biologics - BioBuzz
Wheeler Bio chooses CRB and Lingo for GMP drug facility build - Cleanroom Technology
Frequently Asked Questions About Wheeler Bio
What is Wheeler Bio's CDMO Signal Score?
Wheeler Bio has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Wheeler Bio for a manufacturing program?
Use the free AI matchmaker to compare Wheeler Bio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Boehringer Ingelheim BioXcellence
Ingelheim am Rhein, Germany
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Antibody Fragments, Biosimilars, Biologics
Kemwell Biopharma
Bengaluru, India
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Biosimilars, Cell Therapy, Sterile Fill-Finish
Kemwell Biopharma, Bangalore
Bengaluru, India
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Biosimilars, Cell Therapy, Sterile Fill-Finish, Lyophilized Drug Product
AsymBio
Shanghai, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, ADC, Bioconjugates (NDC, RDC, AOC, PDC, BsADC), Plasmid DNA, mRNA, Fill-Finish
Healsun Biopharm (Hangzhou Healsun Biopharm Co., Ltd.)
Hangzhou, China
Monoclonal Antibody, Recombinant Protein, Bispecific Antibody, Fusion Protein, ADC, XDC (ADC, RDC, Bioconjugates), Cell Line Development (CHO)